ANDREASI, VALENTINA
 Distribuzione geografica
Continente #
EU - Europa 2.209
NA - Nord America 1.911
AS - Asia 1.857
SA - Sud America 270
AF - Africa 41
OC - Oceania 4
Totale 6.292
Nazione #
US - Stati Uniti d'America 1.813
RU - Federazione Russa 1.271
SG - Singapore 614
CN - Cina 608
IT - Italia 305
HK - Hong Kong 247
BR - Brasile 219
SE - Svezia 166
VN - Vietnam 152
DE - Germania 114
FR - Francia 85
GB - Regno Unito 79
CA - Canada 61
IN - India 57
FI - Finlandia 56
BD - Bangladesh 53
JP - Giappone 30
ES - Italia 29
NL - Olanda 23
AR - Argentina 22
MX - Messico 19
PL - Polonia 19
AT - Austria 17
PK - Pakistan 13
TR - Turchia 13
ZA - Sudafrica 12
IE - Irlanda 11
NP - Nepal 11
EC - Ecuador 9
MA - Marocco 8
IQ - Iraq 7
PH - Filippine 7
ID - Indonesia 6
CO - Colombia 5
KE - Kenya 5
LT - Lituania 5
TN - Tunisia 5
UA - Ucraina 5
UZ - Uzbekistan 5
AU - Australia 4
BE - Belgio 4
BO - Bolivia 4
CH - Svizzera 4
IL - Israele 4
JM - Giamaica 4
MD - Moldavia 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
CR - Costa Rica 3
JO - Giordania 3
KR - Corea 3
MY - Malesia 3
PT - Portogallo 3
PY - Paraguay 3
RO - Romania 3
TW - Taiwan 3
AO - Angola 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HN - Honduras 2
KZ - Kazakistan 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
VE - Venezuela 2
AW - Aruba 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CY - Cipro 1
DK - Danimarca 1
EG - Egitto 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
IR - Iran 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
RS - Serbia 1
SC - Seychelles 1
TG - Togo 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 6.292
Città #
Singapore 367
Ashburn 345
Dallas 260
Moscow 251
Hong Kong 239
San Jose 210
Beijing 122
Shanghai 121
New York 112
Milan 93
Los Angeles 90
Hefei 67
Lauterbourg 53
Ho Chi Minh City 52
Boardman 40
Santa Clara 37
São Paulo 37
Hanoi 36
Orem 36
Munich 31
London 28
Helsinki 27
Lawrence 26
Princeton 26
Tokyo 26
Montreal 24
Nuremberg 22
Turku 22
Washington 22
Chennai 20
Rome 20
The Dalles 18
Toronto 18
Cesano Boscone 16
Brooklyn 15
Chicago 15
Columbus 15
Frankfurt am Main 15
Manchester 14
Atlanta 13
Boston 13
Council Bluffs 13
Poplar 13
San Francisco 13
Warsaw 13
Denver 12
Seattle 12
Dublin 11
Guangzhou 11
Falkenstein 10
Houston 10
Mexico City 10
Phoenix 10
Stockholm 9
Amsterdam 8
Johannesburg 8
Kathmandu 8
Mumbai 8
Romagnano Sesia 8
Ankara 7
Buffalo 7
Da Nang 7
Rio de Janeiro 7
Valencia 7
Jinan 6
Lappeenranta 6
New Delhi 6
Pune 6
Barnet 5
Belo Horizonte 5
Dhaka 5
Haiphong 5
Las Vegas 5
Nairobi 5
Tabira 5
Baie-D'Urfé 4
Biên Hòa 4
Brasília 4
Brescia 4
Charlotte 4
Olgiate Olona 4
Ottawa 4
Philadelphia 4
Pittsburgh 4
Portland 4
Shenzhen 4
Sydney 4
São Gonçalo 4
Tashkent 4
The Bronx 4
Thái Bình 4
Verona 4
Vienna 4
Wroclaw 4
Zhengzhou 4
Bologna 3
Bolzano 3
Borgosesia 3
Brussels 3
Bursa 3
Totale 3.390
Nome #
ROLE OF CHROMOGRANIN A-DERIVED FRAGMENTS AND OTHER BIOMARKERS IN PANCREATIC NEOPLASMS: FOCUS ON NEUROENDOCRINE TUMORS 181
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours 179
3D Primary Cell Culture: A Novel Preclinical Model For Pancreatic Neuroendocrine Tumors (PanNETs) 175
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 160
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 160
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 148
Clinical and economic validation of grade B postoperative pancreatic fistula subclassification 142
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms 129
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 128
A preoperative clinical risk score including c-reactive protein predicts histological tumor characteristics and patient survival after surgery for sporadic non-functional pancreatic neuroendocrine neoplasms: An international multicenter cohort study 125
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 118
Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features 117
Circulating Neuroendocrine Gene Transcripts (NETest): A Postoperative Strategy for Early Identification of the Efficacy of Radical Surgery for Pancreatic Neuroendocrine Tumors 114
CT-derived radiomic features to discriminate histologic characteristics of pancreatic neuroendocrine tumors 114
Could Glycated Hemoglobin be Leakage Predictor in Sleeve Gastrectomy? A Retrospective Observational Study on 4233 Patients 113
The role of acinar content at pancreatic resection margin in the development of postoperative pancreatic fistula and acute pancreatitis after pancreaticoduodenectomy 112
ASO Visual Abstract: Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Nonfunctioning Pancreatic Neuroendocrine Tumors 110
Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 106
Preoperative predictive factors of laparoscopic distal pancreatectomy difficulty 106
ASO Visual Abstract: Long-Term Survivors After Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 104
Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) 103
Clinical and Financial Validation of the International Study Group for Pancreatic Surgery (ISGPS) Definition of Post-Pancreatectomy Acute Pancreatitis (PPAP): International Multicenter Prospective Study 102
Critical appraisal of the adequacy of surgical indications for non-functioning pancreatic neuroendocrine tumours 101
Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification 101
Either High or Low Risk: The Acinar Score at the Resection Margin Dichotomizes the Risk Spectrum of Pancreas-specific Complications After Pancreatoduodenectomy 98
Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours 98
Pancreatectomy with venous vascular resection for pancreatic cancer: Impact of types of vein resection on timing and pattern of recurrence 97
How to Select Patients Affected by Neuroendocrine Neoplasms for Surgery 97
Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: Limitations to apply guidelines into real life 96
Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Non-Functioning Pancreatic Neuroendocrine Tumors 95
Diagnostic work-up and surgical management of insulinoma: A retrospective analysis from a tertiary referral center 95
Multidisciplinary management of patients diagnosed with von Hippel-Lindau disease: A practical review of the literature for clinicians 94
A systematic review and meta-analysis on the role of omental or falciform ligament wrapping during pancreaticoduodenectomy 94
Evaluation of cost-effectiveness among open, laparoscopic and robotic distal pancreatectomy: A systematic review and meta-analysis 92
Non functional pancreatic neuroendocrine tumors 92
Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3 91
New Surgical Strategies 89
Is the Real Prevalence of Pancreatic Neuroendocrine Tumors Underestimated? A Retrospective Study on a Large Series of Pancreatic Specimens 87
Diagnosis and Treatment of Pancreatic Neuroendocrine Tumors: How to Deal with them in Clinical Practice? 86
Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma 86
Disease-free survival as a measure of overall survival in resected pancreatic endocrine neoplasms 86
Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms? 86
Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis 85
Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: An endearing tool for preoperative risk assessment 85
Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence? 81
Infiltrative Growth Predicts the Risk of Recurrence After Surgery in Well-Differentiated Non-Functioning Pancreatic Neuroendocrine Tumors 80
Prognostic significance of nodal micrometastases of non-functioning pancreatic neuroendocrine tumours 77
EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs) 76
Local treatment for focal progression in metastatic neuroendocrine tumors 76
Outcomes after distal pancreatectomy for neuroendocrine neoplasms: a retrospective comparison between minimally invasive and open approach using propensity score weighting 76
Safety and cost-effectiveness of immediate right hemicolectomy versus active surveillance for well-differentiated appendiceal neuroendocrine tumors 1-2 cm in size: a Markov decision analysis 75
Exploring definitions of graft pancreatitis following pancreas transplantation: A scoping review 70
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 68
Dual tracer 68ga-dotatoc and 18f-fdg pet improve preoperative evaluation of aggressiveness in resectable pancreatic neuroendocrine neoplasms 68
Histopathological and Immunophenotypic Changes of Pancreatic Neuroendocrine Tumors after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT) 63
Role of Preoperative High-Resolution Manometry in the Identification of Patients at High Risk of Postoperative GERD Symptoms 1 Year After Sleeve Gastrectomy 62
Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors 62
Sporadic non-functioning pancreatic neuroendocrine tumours: multicentre analysis 61
Prognostic role of examined and positive lymph nodes after distal pancreatectomy for non-functioning neuroendocrine neoplasms 57
Role of chromogranin A-derived fragments after resection of nonfunctioning pancreatic neuroendocrine tumors 54
Update on gastroenteropancreatic neuroendocrine tumors 53
Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms 53
Implications of increased serum amylase after pancreaticoduodenectomy: toward a better definition of clinically relevant postoperative acute pancreatitis 53
Evaluation of factors predicting loss of benefit provided by laparoscopic distal pancreatectomy compared to open approach 52
Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management 52
Gender and Age as Preoperative Predictors of Early Disease Progression in Patients Undergoing Surgery for Pancreatic Neuroendocrine Tumors with Liver Metastases 48
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 48
Reply to Letter to the Editor: Role of Preoperative High-Resolution Manometry in the Identification of Patients at High Risk of Postoperative GERD Symptoms 1 Year After Sleeve Gastrectomy 45
Preoperative predictors of new-onset diabetes mellitus following distal pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors 43
Clinico-pathological features and prognosis of mixed-IPMNs with a focal involvement of the main pancreatic duct 3
Mesenteric paraganglioma mimicking nodal metastasis of an occult small intestinal neuroendocrine tumor 1
Surgical management of pancreatic neuroendocrine tumours 1
Totale 6.435
Categoria #
all - tutte 30.322
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.322


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202238 0 1 1 6 4 2 10 1 6 2 2 3
2022/2023303 59 50 23 19 12 44 26 29 17 8 8 8
2023/2024533 19 25 72 54 61 111 6 48 4 13 30 90
2024/20251.307 119 45 47 52 65 125 253 171 138 88 95 109
2025/20264.232 284 241 243 526 428 155 370 333 1.134 245 173 100
Totale 6.435